189 related articles for article (PubMed ID: 11128649)
1. Potent in vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)quinoline derivatives.
Hoemann MZ; Kumaravel G; Xie RL; Rossi RF; Meyer S; Sidhu A; Cuny GD; Hauske JR
Bioorg Med Chem Lett; 2000 Dec; 10(23):2675-8. PubMed ID: 11128649
[TBL] [Abstract][Full Text] [Related]
2. Potent in vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)tetrahydroquinoline derivatives.
Hoemann MZ; Xie RL; Rossi RF; Meyer S; Sidhu A; Cuny GD; Hauske JR
Bioorg Med Chem Lett; 2002 Jan; 12(2):129-32. PubMed ID: 11755337
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of indoloquinoline analogs anti-MRSA.
Zhao M; Kamada T; Takeuchi A; Nishioka H; Kuroda T; Takeuchi Y
Bioorg Med Chem Lett; 2015 Dec; 25(23):5551-4. PubMed ID: 26522949
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effectiveness of common hospital hand disinfectants against methicillin-resistant Staphylococcus aureus, glycopeptide-intermediate S. aureus, and heterogeneous glycopeptide-intermediate S. aureus.
Wootton M; Walsh TR; Davies EM; Howe RA
Infect Control Hosp Epidemiol; 2009 Mar; 30(3):226-32. PubMed ID: 19199533
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial Activity of Quinoline-Based Derivatives against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa: Design, Synthesis, DFT and Molecular Dynamic Simulations.
Sabt A; Abdelraof M; Hamissa MF; Noamaan MA
Chem Biodivers; 2023 Nov; 20(11):e202300804. PubMed ID: 37933986
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
Burchak ON; Pihive EL; Maigre L; Guinchard X; Bouhours P; Jolivalt C; Schneider D; Maurin M; Giglione C; Meinnel T; Paris JM; Denis JN
Bioorg Med Chem; 2011 May; 19(10):3204-15. PubMed ID: 21515059
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Norazah A; Lim VK; Rohani MY; Kamel AG
Med J Malaysia; 2005 Oct; 60(4):411-5. PubMed ID: 16570701
[TBL] [Abstract][Full Text] [Related]
9. Discovery of bisindolyl-substituted cycloalkane-anellated indoles as novel class of antibacterial agents against S. aureus and MRSA.
El-Sayed MT; Suzen S; Altanlar N; Ohlsen K; Hilgeroth A
Bioorg Med Chem Lett; 2016 Jan; 26(1):218-21. PubMed ID: 26590101
[TBL] [Abstract][Full Text] [Related]
10. Quinoline and cyanine dyes--putative anti-MRSA drugs.
Wainwright M; Kristiansen JE
Int J Antimicrob Agents; 2003 Nov; 22(5):479-86. PubMed ID: 14602365
[TBL] [Abstract][Full Text] [Related]
11. 1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors.
Hequet A; Burchak ON; Jeanty M; Guinchard X; Le Pihive E; Maigre L; Bouhours P; Schneider D; Maurin M; Paris JM; Denis JN; Jolivalt C
ChemMedChem; 2014 Jul; 9(7):1534-45. PubMed ID: 24677763
[TBL] [Abstract][Full Text] [Related]
12. Development of novel indole-quinoline hybrid molecules targeting bacterial proton motive force.
Seo J; Kim JH; Ko N; Kim J; Moon K; Kim IS; Lee W
J Appl Microbiol; 2024 May; 135(5):. PubMed ID: 38678002
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial synthesis through disulfide exchange: discovery of potent psammaplin A type antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA).
Nicolaou KC; Hughes R; Pfefferkorn JA; Barluenga S; Roecker AJ
Chemistry; 2001 Oct; 7(19):4280-95. PubMed ID: 11686609
[TBL] [Abstract][Full Text] [Related]
14. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus.
Ambrus JI; Kelso MJ; Bremner JB; Ball AR; Casadei G; Lewis K
Bioorg Med Chem Lett; 2008 Aug; 18(15):4294-7. PubMed ID: 18632270
[TBL] [Abstract][Full Text] [Related]
16. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships.
Yoshizawa H; Itani H; Ishikura K; Irie T; Yokoo K; Kubota T; Minami K; Iwaki T; Miwa H; Nishitani Y
J Antibiot (Tokyo); 2002 Nov; 55(11):975-92. PubMed ID: 12546419
[TBL] [Abstract][Full Text] [Related]
17. Novel synthetic bis-indolic derivatives with antistaphylococcal activity, including against MRSA and VISA strains.
Caspar Y; Jeanty M; Blu J; Burchak O; Le Pihive E; Maigre L; Schneider D; Jolivalt C; Paris JM; Hequet A; Minassian F; Denis JN; Maurin M
J Antimicrob Chemother; 2015; 70(6):1727-37. PubMed ID: 25691323
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship for the oxadiazole class of antibiotics.
Spink E; Ding D; Peng Z; Boudreau MA; Leemans E; Lastochkin E; Song W; Lichtenwalter K; O'Daniel PI; Testero SA; Pi H; Schroeder VA; Wolter WR; Antunes NT; Suckow MA; Vakulenko S; Chang M; Mobashery S
J Med Chem; 2015 Feb; 58(3):1380-9. PubMed ID: 25590813
[TBL] [Abstract][Full Text] [Related]
19. Discovery and initial structure-activity relationships of N-benzyl tricyclic indolines as antibacterials for methicillin-resistant Staphylococcus aureus.
Michael Barbour P; Podoll JD; Marholz LJ; Wang X
Bioorg Med Chem Lett; 2014 Dec; 24(24):5602-5605. PubMed ID: 25466183
[TBL] [Abstract][Full Text] [Related]
20. Discovery of quinoline small molecules with potent dispersal activity against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis biofilms using a scaffold hopping strategy.
Abouelhassan Y; Garrison AT; Burch GM; Wong W; Norwood VM; Huigens RW
Bioorg Med Chem Lett; 2014 Nov; 24(21):5076-80. PubMed ID: 25264073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
